Dapadi Tablet 10 mg (Dapagliflozin Propanediol Monohydrate)
Dapagliflozin Propanediol Hydrate 12.3mg
Tablet · Prescription medication
Kujoo Pharmaceutical Co., Ltd.
MFDS item code 202200564 · Approved 2022.02.07
Effect on blood sugar control in type 2 diabetes and prevention of cardiovascular events
This medication is used to help control blood sugar in patients with type 2 diabetes. It is administered alone or in combination with dietary and exercise therapy to effectively manage blood sugar levels. It is also used in patients who have cardiovascular disease or cardiovascular risk factors and whose blood sugar is not adequately controlled. This medication helps improve blood sugar control and reduce the risk of cardiovascular events.
The recommended dose of this medication for monotherapy and adjunctive therapy is 10 mg once daily. For initial combination therapy, if there is no history of prior diabetes medication treatment, it can be administered in combination with metformin at 5 mg or 10 mg once daily. It may be taken orally at any time of the day, regardless of food intake, and the tablet should be swallowed whole.
The efficacy and safety of dapagliflozin in pediatric patients under the age of 18 have not been established. There is no relevant data.
This medication should not be administered to certain patients. For example, it should not be used by individuals who are allergic to any of its components, patients with type 1 diabetes, patients with diabetic ketoacidosis, or those undergoing dialysis. Caution should be exercised when prescribing this medication to patients with reduced fluid volume or impaired kidney function. This drug can lower blood pressure or affect kidney function, so special care is needed for the elderly or patients taking diuretics. While taking this medication, symptoms of side effects such as hypoglycemia, genital infections, urinary tract infections, reduced fluid volume, and diabetic ketoacidosis should be carefully monitored. Especially, genital infections may occur more commonly in women, and those with a history of prior infections may have a higher risk of recurrence. The risk of hypoglycemia may increase when this medication is used in conjunction with drugs that can induce hypoglycemia such as insulin or sulfonylureas, and dose adjustments may be necessary. Women who are pregnant or breastfeeding should avoid using this medication, and it should be discontinued if pregnancy is confirmed. The safety and efficacy of this medication have not been established in children, so it is not used in this population. In the event of an overdose, there is no specific antidote, so appropriate treatment should be provided based on symptoms, and careful management of dehydration and hypotension symptoms is required. This medication does not have a significant impact on driving or machine operation, but caution is needed when taken with medications at risk for hypoglycemia. Finally, this medication should be stored in its original container, out of the reach of children, and it is safest not to change the container arbitrarily.
Hives, severe swelling (edema), chest tightness, difficulty breathing, cold sweat, pallor, severe rash with fever, blisters, skin peeling, oral/eye mucosal pain, shortness of breath or difficulty breathing, asthma attacks, respiratory issues with cough and fever, yellowing of the skin or eyes (jaundice), extreme lethargy, sudden and severe headache, thunderclap headache, seizures, altered consciousness, visual disturbances, paralysis, urinary abnormalities
Vulvovaginitis, balanitis and related genital infections, urinary tract infections, fungal infections, hypoglycemia, thirst, dizziness, constipation, dry mouth, back pain, dysuria, polyuria, nocturia, interstitial nephritis, elevated hematocrit, increased serum creatinine, dyslipidemia, weight loss, rash, angioedema, gastrointestinal disorders (gastroesophageal reflux disease, upper abdominal pain, diverticulitis, intestinal perforation, acute pancreatitis, chronic pancreatitis, chronic gastritis, intestinal gas retention)
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to protect it from air and moisture, ideally at a temperature between 1 and 30 degrees Celsius. Storing it this way will help maintain the drug's effectiveness.
Yellow, biconvex, diamond-shaped film-coated tablet
28 tablets/PTP [7 tablets/Alu-Alu x 4], 30 tablets/bottle, 28 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Dapagliflozin Propanediol Hydrate 12.3mg
Tablet · Prescription medication
Kujoo Pharmaceutical Co., Ltd.
Dapagliflozin Propanediol Hydrate 6.15mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.
Dapagliflozin Propanediol Hydrate 12.3mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Dapagliflozin Propanediol Hydrate 12.3mg
Tablet · Prescription medication
Donggu Bio Pharmaceutical Co., Ltd.
Dapagliflozin Propanediol Hydrate 12.3mg
Tablet · Prescription medication
Il Sung IS Co., Ltd.
Dapagliflozin Propanediol Hydrate
Prescription medication
Optus Pharmaceutical Co., Ltd.

Dapagliflozin Propanediol Hydrate 12.3mg
Tablet · Prescription medication
Aprogen Biologics Co., Ltd.

Dapagliflozin Propanediol Hydrate 12.3mg
Tablet · Prescription medication
Il Yang Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.